These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1358080)

  • 1. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
    Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
    Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacological effects of tianeptine analogous hetero[2,1] benzothiazepine derivatives.
    Sánchez-Mateo CC; Darias V; Albertos LM; Expósito-Orta MA
    Arzneimittelforschung; 2003; 53(1):12-20. PubMed ID: 12608009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effects of thieno and pyrazolo [2,1] benzothiazepine derivatives in mice.
    Expósito-Orta MA; Albertos LM; Darias V; Sánchez-Mateo CC
    Arzneimittelforschung; 2004; 54(7):365-70. PubMed ID: 15344839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of 4-substituted-1-piperazinyl-propyl derivatives of 1-phenyl-7-methylpyrimido-[4,5-d]pyrimidin-4-one.
    Malinka W; Zajac HE; Dereń A; Zawisza T; Wilimowski M; Kedzierska-Goździk L; Barczyńska J; Rutkowska M; Wojewódzki W; Szelag A
    Pol J Pharmacol Pharm; 1991; 43(5):369-79. PubMed ID: 1688093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
    Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
    J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics.
    Chakrabarti JK; Horsman L; Hotten TM; Pullar IA; Tupper DE; Wright FC
    J Med Chem; 1980 Aug; 23(8):878-84. PubMed ID: 6105216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10-Piperazinyl-4H-theino[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics.
    Chakrabarti JK; Fairhurst J; Gutteridge NJ; Horsman L; Pullar IA; Smith CW; Steggles DJ; Tupper DE; Wright FC
    J Med Chem; 1980 Aug; 23(8):884-9. PubMed ID: 6105217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents.
    Bristow LJ; Flatman KL; Hutson PH; Kulagowski JJ; Leeson PD; Young L; Tricklebank MD
    J Pharmacol Exp Ther; 1996 May; 277(2):578-85. PubMed ID: 8627534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative.
    Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A
    Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amoxapine in experimental psychopharmacology: a neuroleptic or an antidepressant?
    Chermat R; Simon P; Boissier JR
    Arzneimittelforschung; 1979; 29(5):814-20. PubMed ID: 40575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
    Korzycka L; Szadowska A; Pakulska W
    Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
    Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
    J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New thieno and pyrazolo[2,1]benzothiazepine derivatives with antidepressant activity.
    Darias V; Sánchez-Mateo CC; Expósito-Orta MA; Albertos LM; Díaz JA; Vega S
    Pharmazie; 1999 Oct; 54(10):783-4. PubMed ID: 10563378
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study.
    Liégeois JF; Rogister FA; Bruhwyler J; Damas J; Nguyen TP; Inarejos MO; Chleide EM; Mercier MG; Delarge JE
    J Med Chem; 1994 Feb; 37(4):519-25. PubMed ID: 7907148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841.
    Krisch I; Bole-Vunduk B; Pepelnak M; Lavric B; Ocvirk A; Budihna MV; Sket D
    J Pharmacol Exp Ther; 1994 Oct; 271(1):343-52. PubMed ID: 7965734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.